Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Grand House Mulia Tbk. (HOMI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Grand House Mulia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Grand House Mulia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Grand House Mulia Tbk. trades at Rp181 (market cap 288.23B, 619.8K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.14M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2× Grand House Mulia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.14M versus 619.8K). Which is the better fit depends on your goals.

HOMILABS
Market Cap
288.23B576.7B
Volume
619.8K3.14M
Lot
6.2K31.41K
Turnover
111.62M472.54M
Average Price
180.09150.43
Value
111.62M472.54M
Indicative Equilibrium Price
184147
Indicative Equilibrium Volume
1311

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HOMI
View details
LABS
View details

About Grand House Mulia Tbk.

PT Grand House Mulia, Tbk (“the Company”) was established in Republic of Indonesia based on the Notarial Deed No. 1 dated January 9, 2006 of Suryati Moerwibowo, S.H., The Company has commercially operated in April 2019.

Read more on HOMI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS